P129 - The impact of concomitant treatment with immuno-modulators and antibiotics on the outcome of C. difficile -associated inflammatory bowel disease exacerbation: an ECCO multi-center retrospective study

P129 The impact of concomitant treatment with immuno-modulators and antibiotics on the outcome of C. difficile-associated inflammatory bowel disease exacerbation: an ECCO multi-center retrospective study S. Ben-Horin1 *, M. Margalit2, P. Bossuyt3, J. Maul4, Y. Shapira5, D. Bojic6, I. Chermesh7, A. Al-Rifai8, A. Schoepfer9, M. Bosani10, M. Allez11, P.L. Lakatos12, F. Bossa13, A. Eser14, T. Stefanelli15, F. Carbonnel16, K. Katsanos17, D. Checchin18, I. Saenz de Miera19, Y. Chowers1, G.W. Moran20. 1Sheba Medical Center, Ramat-Gan, Israel, 2Haddassa Medical Center, Hebrew University, Jerusalem, Israel, 3University of Leuven Hospitals, Leuven, Belgium, 4Charite-Universitatsmedizin, Berlin, Germany, 5Tel-Aviv Medical Center, Tel-Aviv, Israel, 6Zvezdara University Medical Center, Belgrade, Serbia, 7Rambam Medical Center, Haifa, Israel, 8Salford NHS University Hospital, Manchester, United Kingdom, 9University Hospital of Bern, Bern, Switzerland, 10Sacco University Hospital, Milan, Italy, 11Saint-Louis Hospital, Paris, France, 12Semmelweis University, Budapest, Hungary, 13Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy, 14Medical University of Vienna, Vienna, Austria, 15Universita degli Studi di Milano, Milan, Italy, 16University hospital of Besancon, Besancon, France, 17Univeristy Hospital of Ioannina, Ioannina, Greece, 18University of Padua, Padua, Italy, 19Hospital General Yague, Burgos, Spain, 20University of Birmingham, Birmingham, United Kingdom